PPIs effect in EGFR-TKI-associated interstitial lung diseases in patients with non-small cell lung cancer.

Our findings unveiled that the combination of lansoprazole or esomeprazole with EGFR-TKI was significantly associated with a higher reporting of ILD events, while the combination of other PPIs with EGFR-TKI therapy did not reach statistical significance (Table 2 ).

also in 111,027 other papers